ArticleEJHaem2025

Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis.

Alberto Blanco-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.